137 related articles for article (PubMed ID: 38040204)
21. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.
Wang MG; Wu SQ; Zhang MM; He JQ
Front Immunol; 2022; 13():1002126. PubMed ID: 36483548
[TBL] [Abstract][Full Text] [Related]
22. An In Silico Model for Predicting Drug-Induced Hepatotoxicity.
He S; Ye T; Wang R; Zhang C; Zhang X; Sun G; Sun X
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999595
[TBL] [Abstract][Full Text] [Related]
23. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
[TBL] [Abstract][Full Text] [Related]
24. AI/ML Models to Predict the Severity of Drug-Induced Liver Injury for Small Molecules.
Rao M; Nassiri V; Alhambra C; Snoeys J; Van Goethem F; Irrechukwu O; Aleo MD; Geys H; Mitra K; Will Y
Chem Res Toxicol; 2023 Jul; 36(7):1129-1139. PubMed ID: 37294641
[TBL] [Abstract][Full Text] [Related]
25. Predicting Drug-Induced Liver Injury with Bayesian Machine Learning.
Williams DP; Lazic SE; Foster AJ; Semenova E; Morgan P
Chem Res Toxicol; 2020 Jan; 33(1):239-248. PubMed ID: 31535850
[TBL] [Abstract][Full Text] [Related]
26. Predicting Drug-Induced Liver Injury Using Ensemble Learning Methods and Molecular Fingerprints.
Ai H; Chen W; Zhang L; Huang L; Yin Z; Hu H; Zhao Q; Zhao J; Liu H
Toxicol Sci; 2018 Sep; 165(1):100-107. PubMed ID: 29788510
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced liver injury and drug development: industry perspective.
Regev A
Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
[TBL] [Abstract][Full Text] [Related]
28. Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs.
Zhang H; Zhang HR; Hu ML; Qi HZ
J Pharmacol Toxicol Methods; 2022; 116():107185. PubMed ID: 35623583
[TBL] [Abstract][Full Text] [Related]
29. In-silico approach for drug induced liver injury prediction: Recent advances.
Saini N; Bakshi S; Sharma S
Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
[TBL] [Abstract][Full Text] [Related]
30. Computational models for predicting liver toxicity in the deep learning era.
Mostafa F; Chen M
Front Toxicol; 2023; 5():1340860. PubMed ID: 38312894
[TBL] [Abstract][Full Text] [Related]
31. Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints.
Liu X; Zheng D; Zhong Y; Xia Z; Luo H; Weng Z
Biomed Res Int; 2020; 2020():4795140. PubMed ID: 32509859
[TBL] [Abstract][Full Text] [Related]
32. Identification of intrinsic hepatotoxic compounds in Polygonum multiflorum Thunb. using machine-learning methods.
Hu X; Du T; Dai S; Wei F; Chen X; Ma S
J Ethnopharmacol; 2022 Nov; 298():115620. PubMed ID: 35963419
[TBL] [Abstract][Full Text] [Related]
33. Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury.
Shimizu Y; Sasaki T; Yonekawa E; Yamazaki H; Ogura R; Watanabe M; Hosaka T; Shizu R; Takeshita JI; Yoshinari K
J Toxicol Sci; 2021; 46(4):167-176. PubMed ID: 33814510
[TBL] [Abstract][Full Text] [Related]
34. Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.
Shin HK; Kang MG; Park D; Park T; Yoon S
Front Pharmacol; 2020; 11():67. PubMed ID: 32116729
[TBL] [Abstract][Full Text] [Related]
35. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
36. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
37. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
[TBL] [Abstract][Full Text] [Related]
38. Current challenges and controversies in drug-induced liver injury.
Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
[TBL] [Abstract][Full Text] [Related]
39. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
40. Improved Detection of Drug-Induced Liver Injury by Integrating Predicted
Seal S; Williams DP; Hosseini-Gerami L; Mahale M; Carpenter AE; Spjuth O; Bender A
bioRxiv; 2024 Jun; ():. PubMed ID: 38895462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
